- Pfizer (NYSE:PFE) Q1 results ($M): Total Revenues: 10,864 (-4.3%); GEP: 5,014 (-16.3%); GIP: 3,075 (0.0%); Global Vaccines: 1,328 (+43.6%); Consumer Healthcare: 808 (+6.3%); Global Oncology: 528 (+8.2%); Net Income: 2,376 (+2.0%); EPS: 0.38 (+5.6%).
- Repurchased $6B in common stock, no additional buybacks this year.
- Non-GAAP EPS lowered due unfavorable foreign exchange trend vs. dollar.
- 2015 Guidance: Revenues: $44.0B - 46.0B from $44.5B - 46.5B; GAAP EPS: $1.32 - 1.47 from $1.37 - 1.52; Non-GAAP EPS: $1.95 - 2.05 from $2.00 - 2.10.